Founders Fund VI Management LLC purchased a new stake in shares of Cyclo Therapeutics, Inc. (NASDAQ:CYTH – Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 110,023 shares of the company’s stock, valued at approximately $175,000. Cyclo Therapeutics comprises […]
Founders Fund V Management LLC bought a new position in shares of Cyclo Therapeutics, Inc. (NASDAQ:CYTH – Free Report) during the 4th quarter, according to its most recent disclosure with the SEC. The fund bought 480,708 shares of the company’s stock, valued at approximately $764,000. Cyclo Therapeutics accounts for 80.8% of Founders Fund V Management […]
Avidity Partners Management LP lifted its position in shares of Neumora Therapeutics, Inc. (NASDAQ:NMRA – Free Report) by 10.6% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,990,632 shares of the company’s stock after purchasing an additional 190,632 shares during the quarter. Avidity Partners […]
Bellevue Group AG boosted its stake in shares of Celldex Therapeutics, Inc. (NASDAQ:CLDX – Free Report) by 27.2% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 2,416,296 shares of the biopharmaceutical company’s stock after purchasing an additional 516,296 shares during the […]
Bellevue Group AG increased its stake in Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) by 0.6% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 635,372 shares of the company’s stock after purchasing an additional 3,885 shares during the quarter. Bellevue Group AG owned 1.34% […]